Genelux (GNLX) Stock: Buy, Sell, or Hold?
GNLX - Genelux Corporation Common Stock
$2.56
0.04 (1.59%)
â˛
5d:
+3.23%
30d:
+0.39%
90d:
-15.23%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When GNLX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: GNLX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: GNLX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: GNLX is currently trading at $2.56, which is considered fair relative to its 30-day fair value range of $2.44 to $2.65.
Technical Outlook: Technically, GNLX is in a strong downtrend. Immediate support is located at $2.41, while resistance sits at $2.64.
Market Sentiment: GNLX scores 74/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $18.83 (+635.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GNLX is in a strong downtrend. Immediate support is located at $2.41, while resistance sits at $2.64.
Market Sentiment: GNLX scores 74/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $18.83 (+635.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.44 -
$2.65
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (74/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 635.7% below Wall St target ($18.83)
- WARNING: Composite score 52/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.44 -
$2.65
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$2.41
Resistance Level
$2.64
Current Trend
Strong Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.41
Wall Street Target
$18.83
(+635.7%)
Revenue Growth (YoY)
-95.3%
Share & Embed Analysis
Last updated: October 03, 2026 3:56 PM ET
Data refreshes hourly during market hours. Next update: 4:56 PM
Data refreshes hourly during market hours. Next update: 4:56 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GNLX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$84 | 71 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$75 | 60 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$95 | 57 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$52 | 66 BUY |
